Impact Biomedical Inc. Announces Board and Officer Changes
Ticker: IBO · Form: 8-K · Filed: Jun 7, 2024 · CIK: 1834105
| Field | Detail |
|---|---|
| Company | Impact Biomedical Inc. (IBO) |
| Form Type | 8-K |
| Filed Date | Jun 7, 2024 |
| Risk Level | medium |
| Pages | 3 |
| Reading Time | 4 min |
| Key Dollar Amounts | $0.001, $250 million, $150 million |
| Sentiment | neutral |
Sentiment: neutral
Topics: leadership-change, board-of-directors, officer-appointment
TL;DR
Impact Biomedical Inc. shakes up leadership with new directors and officers appointed.
AI Summary
Impact Biomedical Inc. announced on June 6, 2024, changes in its board and officer appointments. Specifically, the company elected new directors and appointed certain officers, alongside updates to compensatory arrangements for these officers. The filing details the departure of directors and the election of new ones, as well as the appointment of key officers.
Why It Matters
Changes in board composition and officer appointments can signal shifts in company strategy, leadership, and future direction.
Risk Assessment
Risk Level: medium — Changes in corporate leadership can introduce uncertainty regarding future strategy and execution.
Key Players & Entities
- Impact Biomedical Inc. (company) — Registrant
- Nevada (jurisdiction) — State of incorporation
- June 6, 2024 (date) — Date of earliest event reported
FAQ
What specific roles have been filled by the newly appointed officers?
The filing indicates the appointment of certain officers but does not specify their exact roles in this summary.
Who are the directors that have departed from Impact Biomedical Inc.?
The filing mentions the departure of directors but does not name them in the provided text.
What are the details of the compensatory arrangements for the newly appointed officers?
The filing notes updates to compensatory arrangements but does not provide specific details on the amounts or terms.
When was the earliest event reported in this 8-K filing?
The earliest event reported was on June 6, 2024.
What is the principal executive office address for Impact Biomedical Inc.?
The principal executive offices are located at 1400 Broadfield Blvd., Suite 130, Houston, TX 77084.
Filing Stats: 893 words · 4 min read · ~3 pages · Grade level 12.2 · Accepted 2024-06-07 16:05:32
Key Financial Figures
- $0.001 — nge on which registered Common Stock, $0.001 par value per share N/A N/A Indic
- $250 million — ted the acquisition of assets exceeding $250 million and secured capital investments totalin
- $150 million — nd secured capital investments totaling $150 million through adept negotiations in investmen
Filing Documents
- form8-k.htm (8-K) — 41KB
- 0001493152-24-023096.txt ( ) — 209KB
- impb-20240606.xsd (EX-101.SCH) — 3KB
- impb-20240606_lab.xml (EX-101.LAB) — 33KB
- impb-20240606_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 3KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this Current Report on Form 8-K to be signed on its behalf by the undersigned hereunto duly authorized. IMPACT BIOMEDICAL INC. Date: June 7, 2024 By: /s/ Frank D. Heuszel Name: Frank D. Heuszel Title: Chief Executive Officer